Endo Health Solutions Pleads Guilty, Agrees to Pay $2 Billion to Resolve Fines, Bankruptcy

Bankrupt Endo Health Solutions (EHSI) has agreed to plead guilty and pay just over $2 billion to resolve criminal and civil investigations, as well as its bankruptcy debt, related to the company’s sales and marketing of the opioid drug Opana ER (oxymorphone), the Department of Justice (DOJ) announced.

Under the bankruptcy agreement, EHSI will pay the government up to $464.9 million over 10 years. Under the proposed criminal resolution, EHSI agreed to plead guilty in federal court in the Eastern District of Michigan to a one-count misdemeanor charging it with violating the Federal Food, Drug and Cosmetic Act by introducing misbranded drugs into interstate commerce.

The DOJ said the criminal resolution includes the second-largest set of criminal financial penalties ever levied against a pharmaceutical company, and includes a criminal fine of $1.086 billion and an additional $450 million in criminal forfeiture.

To read the whole story, click here to subscribe.

Related Topics